0001209191-18-037075.txt : 20180611
0001209191-18-037075.hdr.sgml : 20180611
20180611181106
ACCESSION NUMBER: 0001209191-18-037075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180607
FILED AS OF DATE: 20180611
DATE AS OF CHANGE: 20180611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Gilmore Neil
CENTRAL INDEX KEY: 0001742084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 18893108
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-07
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001742084
O'Neill Gilmore Neil
215 FIRST STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP & Chief Medical Officer
Stock option (right to buy)
96.23
2018-06-07
4
A
0
100000
0.00
A
2028-06-07
Common Stock
100000
100000
D
Restricted Stock Units
2018-06-07
4
A
0
12000
0.00
A
2019-05-23
Common Stock
12000
12000
D
25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.
Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.
The restricted stock units will vest on May 23, 2019.
/s/ David Tyronne Howton, as Attorney-in-Fact for Gilmore Neil O'Neill
2018-06-11